文献速递慢性肾脏病血液净化与透析

体能表现与CKD患者心力衰竭、肾衰竭及死亡风险:CRIC研究

Physical Performance and Risk of Heart Failure, Kidney Failure, and Mortality in CKD: Findings from the CRIC Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-09-29

本研究基于CRIC队列3038名CKD患者,每2-3年评估简易体能评分(SPPB),中位随访8.5年。基线SPPB每低1分与死亡风险升高14%相关,但校正后与心衰和肾衰竭无关;时间更新分析中SPPB每低1分与心衰风险升高10%、死亡风险升高15%相关。SPPB与肾衰竭无独立关联,提示其可用于CKD患者心血管和死亡风险分层。

要点

  • 基线SPPB每低1分,全因死亡风险升高14%,与心衰和肾衰竭无独立关联。
  • 时间更新SPPB每低1分,心衰风险升高10%,死亡风险升高15%。
  • 低/中SPPB较高SPPB,心衰风险分别升高51%和128%,死亡风险升高69%和224%。

核心结论

  • 纵向体能表现较差与CKD患者心衰和死亡风险升高独立相关,但与肾衰竭无关。
  • SPPB可能有助于对CKD患者进行心血管结局和死亡的风险分层。

研究设计与样本

  • 慢性肾功能不全队列(CRIC)研究,纳入至少一次SPPB评估的3038名参与者。
  • SPPB约每2-3年评估一次,采用病因特异性Cox模型校正人口学和临床特征。

主要发现

  • 平均年龄63.5岁,40%为非西班牙裔黑人,平均eGFR为52 mL/min/1.73m2,中位随访8.5年,基线SPPB中位数10(8-11)。
  • 基线SPPB每低1分与死亡风险升高14%相关,但与心衰和肾衰竭无独立关联。
  • 时间更新SPPB每低1分与心衰风险升高10%和死亡风险升高15%相关。
  • 低和中等(较高)SPPB类别分别与心衰风险升高51%和128%、死亡风险升高69%和224%相关。
  • 基线和时间更新SPPB均与肾衰竭无独立关联。

临床怎么用

  • 在CKD患者中可考虑使用SPPB评估体能,以识别心衰和死亡高风险个体。
  • SPPB不宜单独用于肾衰竭风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Physical performance limitations are common in chronic kidney disease (CKD) and affect independence and survival, yet physical performance is not routinely assessed. We examined whether the Short Physical Performance Battery (SPPB), a multidimensional measure of lower-extremity physical performance, was longitudinally associated with incident heart failure, kidney failure, and mortality. METHODS: We evaluated Chronic Renal Insufficiency Cohort (CRIC) Study participants with ≥1 SPPB assessment, administered approximately every 2-3 years. SPPB was modeled per 1-point lower score, and categorically as low (0-6), moderate (7-9), and high (10-12) performance. Associations of baseline and time-updated SPPB with incident heart failure, incident kidney failure and mortality were evaluated using cause-specific Cox models adjusted for demographic and clinical characteristics. RESULTS: Among 3,038 participants, mean age was 63.5 years, 40% were non-Hispanic Black, and mean estimated glomerular filtration rate (eGFR) was 52 mL/min/1.73m2. Median follow-up was 8.5 years, and median baseline SPPB was 10 (8-11). Each 1-point lower baseline SPPB score was associated with 14% higher mortality risk but was not heart failure or kidney failure after full adjustment. In time-updated analyses, each 1-point lower SPPB was associated with a 10% higher heart failure risk and a 15% higher mortality risk. Low and moderate (vs high) SPPB performance categories were associated with 51% and 128% higher heart failure risk and 69% and 224% higher mortality risk, respectively. In contrast, neither baseline nor time-updated SPPB was independently associated with kidney failure. CONCLUSIONS: Lower longitudinal physical performance was independently associated with higher risks of heart failure and mortality, but not kidney failure, among adults with CKD. The SPPB may help risk-stratify patients with CKD identifying those at high-risk for cardiovascular outcomes and mortality.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Nair D, Brown RT, Shlipak MG, et al. Physical Performance and Risk of Heart Failure, Kidney Failure, and Mortality in CKD: Findings from the CRIC Study. Clin J Am Soc Nephrol. 2026. PMID: 42809358. doi:10.2215/CJN.0000001219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。